Efficacy and safety of tocilizumab in patients with systemic juvenile idiopathic arthritis (sJIA): 12-week data from the phase 3 TENDER trial

Authors
Category Primary study
JournalClin Exp Rheumatol
Year 2011
This article has no abstract
Epistemonikos ID: ff2cc2c95536e739202d3b1060924127582098fc
First added on: Sep 02, 2019